Display options
Cite
Kumar S, Brown A, Tchounwou PB. Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells. Oncotarget. 2018;9(69):33138-33148doi: 10.18632/oncotarget.26025.
Kumar, S., Brown, A., & Tchounwou, P. B. (2018). Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells. Oncotarget, 9(69), 33138-33148. https://doi.org/10.18632/oncotarget.26025
Kumar, Sanjay, et al. "Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells." Oncotarget vol. 9,69 (2018): 33138-33148. doi: https://doi.org/10.18632/oncotarget.26025
Kumar S, Brown A, Tchounwou PB. Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells. Oncotarget. 2018 Sep 04;9(69):33138-33148. doi: 10.18632/oncotarget.26025. eCollection 2018 Sep 04. PMID: 30237857; PMCID: PMC6145703.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2018 Sep 04;9(69):33138-33148. doi: 10.18632/oncotarget.26025. eCollection 2018 Sep 04.

Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells.

Oncotarget

Sanjay Kumar, Andrea Brown, Paul B Tchounwou

Affiliations

  1. Cellomics and Toxicogenomics Research Laboratory, NIH/NIMHD-RCMI Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, Jackson, Mississippi, MS 39217, USA.

PMID: 30237857 PMCID: PMC6145703 DOI: 10.18632/oncotarget.26025

Abstract

Trisenox (TX) has been used in the treatment of both

Keywords: APL; MDM2-DAXX-HAUSP complex; apoptosis; p53; trisenox

Conflict of interest statement

CONFLICTS OF INTEREST Authors declare no conflicts of interest.

References

  1. Blood. 1991 Sep 15;78(6):1413-9 - PubMed
  2. EMBO J. 1999 Nov 1;18(21):6037-49 - PubMed
  3. EMBO J. 2008 Jul 9;27(13):1863-74 - PubMed
  4. Blood. 1998 Jun 1;91(11):4300-10 - PubMed
  5. Trends Cell Biol. 2010 May;20(5):299-309 - PubMed
  6. Blood. 2009 Feb 26;113(9):1875-91 - PubMed
  7. Cancer Cell. 2017 May 8;31(5):697-710.e7 - PubMed
  8. Mol Cell Biol. 2017 Aug 11;37(17): - PubMed
  9. Int J Cancer. 2001 Jan 15;91(2):173-9 - PubMed
  10. Int J Environ Res Public Health. 2014 May 09;11(5):5006-19 - PubMed
  11. Oncotarget. 2016 Mar 15;7(11):12951-61 - PubMed
  12. Expert Rev Anticancer Ther. 2011 Sep;11(9):1317-9 - PubMed
  13. Biochem Biophys Res Commun. 1993 Nov 30;197(1):40-5 - PubMed
  14. Blood Rev. 2010 Jul-Sep;24(4-5):191-9 - PubMed
  15. J Exp Med. 2013 Dec 16;210(13):2793-802 - PubMed
  16. Blood. 2003 May 15;101(10):4078-87 - PubMed
  17. Blood. 2008 Mar 1;111(5):2505-15 - PubMed
  18. Nat Med. 2008 Dec;14(12):1333-42 - PubMed
  19. Blood. 1994 Jan 1;83(1):10-25 - PubMed
  20. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8 - PubMed
  21. Cancer Cell. 2012 May 15;21(5):595-6 - PubMed
  22. Blood. 1997 May 1;89(9):3345-53 - PubMed
  23. Cytometry A. 2011 Jul;79(7):507-17 - PubMed
  24. Cancer Res. 2010 Dec 1;70(23):9895-904 - PubMed
  25. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10173-8 - PubMed
  26. Blood. 1990 Nov 1;76(9):1704-9 - PubMed
  27. J Exp Clin Cancer Res. 2014 May 16;33:42 - PubMed
  28. Nat Rev Cancer. 2002 Aug;2(8):594-604 - PubMed
  29. Mol Cell Biochem. 2009 Nov;331(1-2):207-14 - PubMed
  30. Blood Cancer J. 2015 Apr 17;5:e304 - PubMed
  31. Nat Cell Biol. 2006 Aug;8(8):855-62 - PubMed
  32. Nat Rev Cancer. 2009 Oct;9(10):714-23 - PubMed
  33. Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35 - PubMed
  34. Leukemia. 2008 Apr;22(4):730-9 - PubMed
  35. Blood. 1998 Dec 1;92(11):4308-16 - PubMed
  36. Blood. 1988 Aug;72(2):567-72 - PubMed
  37. Ann Hematol. 2015 Nov;94(11):1829-37 - PubMed
  38. Nat Med. 2014 Feb;20(2):167-74 - PubMed
  39. Oncotarget. 2015 Dec 1;6(38):40734-46 - PubMed
  40. Nat Cell Biol. 2000 Oct;2(10):730-6 - PubMed
  41. Leukemia. 2012 Mar;26(3):433-42 - PubMed
  42. Cancer Res. 2000 Jun 1;60(11):3065-71 - PubMed
  43. Eur J Haematol. 1998 Jul;61(1):27-35 - PubMed
  44. Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):959-71 - PubMed
  45. Leukemia. 2003 Feb;17(2):339-42 - PubMed
  46. J Clin Oncol. 2011 Feb 10;29(5):495-503 - PubMed
  47. Int J Hematol. 2013 Jun;97(6):717-25 - PubMed
  48. N Engl J Med. 1997 Oct 9;337(15):1021-8 - PubMed
  49. Leukemia. 1998 Sep;12(9):1383-91 - PubMed
  50. Nature. 2000 Nov 16;408(6810):307-10 - PubMed
  51. J Biol Chem. 2014 Jul 4;289(27):18641-56 - PubMed
  52. J Hematol Oncol. 2010 Aug 26;3:28 - PubMed
  53. Cancer Res. 2002 Jul 15;62(14):3893-903 - PubMed
  54. N Engl J Med. 2013 Jul 11;369(2):111-21 - PubMed
  55. Nat Rev Cancer. 2013 Feb;13(2):83-96 - PubMed

Publication Types

Grant support